GGrantIndex
← Leaderboards

Michael R Yeaman

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center

$18,135,333
Attributed
$18,135,333
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.3M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,110,889 · 11

By mechanism

U01$10,142,736 · 1
U19$9,414,416 · 3
R01$3,312,695 · 2
R33$1,181,839 · 1
R41$450,000 · 1
R21$378,390 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Antibiotics

Research focus

AntibioticsPathogenPreventIn VitroInfectionStaphylococcus AureusLifeInnovationUnited States National Institutes Of HealthAntibiotic ResistanceBlood CirculationNovel StrategiesDesignIn VivoNeutrophilPhenotypeGeneticProgramsMicrobial BiofilmsInsightResponseSystems BiologyGenesAnti-Infective Agents

Grant awards (33)

Systems Epigenomics of Persistent Bloodstream Infection$2,326,682
U19 · FY2025 · AI · contact PI
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia$597,740
U19 · FY2025 · AI · contact PI
Administrative Core$179,100
U19 · FY2025 · AI · contact PI
Systems Epigenomics of Persistent Bloodstream Infection$2,344,235
U19 · FY2024 · AI · contact PI
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia$626,031
U19 · FY2024 · AI · contact PI
Administrative Core$346,210
U19 · FY2024 · AI · contact PI
Systems Epigenomics of Persistent Bloodstream Infection$2,304,639
U19 · FY2023 · AI · contact PI
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia$528,279
U19 · FY2023 · AI · contact PI
Administrative Core$161,500
U19 · FY2023 · AI · contact PI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,947,150
U01 · FY2020 · AI · contact PI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,962,994
U01 · FY2019 · AI · contact PI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$2,291,458
U01 · FY2018 · AI · contact PI
Mitigating Resistance & Virulence in MRSA$393,685
R33 · FY2018 · AI · contact PI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,941,212
U01 · FY2017 · AI · contact PI
Mitigating Resistance & Virulence in MRSA$394,079
R33 · FY2017 · AI · contact PI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,999,922
U01 · FY2016 · AI · contact PI
Mitigating Resistance & Virulence in MRSA$394,075
R33 · FY2016 · AI · contact PI
Mitigating Resistance & Virulence in MRSA$188,122
R21 · FY2015 · AI · contact PI
Mitigating Resistance & Virulence in MRSA$190,268
R21 · FY2014 · AI · contact PI
Microbicidal Proteins from Platelets$344,495
R01 · FY2010 · AI · contact PI
Microbicidal Proteins from Platelets$345,575
R01 · FY2009 · AI · contact PI
Microbicidal Proteins from Platelets$343,245
R01 · FY2008 · AI · contact PI
Novel Context-Activated Protide Anti-Infectives$227,738
R41 · FY2008 · AI · contact PI
Microbicidal Proteins from Platelets$347,587
R01 · FY2007 · AI · contact PI
Novel Context-Activated Protide Anti-Infectives$222,262
R41 · FY2007 · AI · contact PI
Microbicidal Proteins from Platelets$326,862
R01 · FY2006 · AI · contact PI
DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS$339,495
R01 · FY2004 · AI
DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS$329,606
R01 · FY2003 · AI
DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS$320,007
R01 · FY2002 · AI
DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS$310,686
R01 · FY2001 · AI
CORE FACILITY RESEARCH PEPTIDE SYNTHESIZER$132,083
S10 · FY2001 · RR
DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS$305,137
R01 · FY2000 · AI
MICROBICIDAL PROTEINS FROM PLATELETS$98,730
R29 · FY2000 · AI